CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

Analysts have also weighed in on stock throughout the month. Recent analyst calls on the stock include: Needham analyst Gil ...

Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to ...

A Ph.D. student in biomolecular engineering at the University of California, Santa Cruz, has built a software program ...

CRISPR Therapeutics (NasdaqGM:CRSP) witnessed a substantial price movement, increasing 57% over the last quarter. This significant rise aligns with key developments, such as the company's inclusion in ...

UC Berkeley and Caltech researchers identified a gene circuit in zebrafish that allows heart regeneration after injury. Using ...

It’s time to step up the opposition to designer babies, says Marcy Darnovsky of the Center for Genetics and Society ...

The global CRISPR gene editing market size is calculated at USD 4.77 billion in 2025 and is expected to reach around USD ...

New research has found a novel target with therapeutic potential for metastatic eye melanoma—an aggressive eye cancer—with ...

CRISPR, which stands for clustered regularly interspaced short palindromic repeats, is part of that bacterial immune system. "Palindromic" means any sequence that reads the same forward and backward.

UC Davis scientists spent years editing a sex-determining gene into bovine embryos using Crispr. In April, Cosmo arrived—and his DNA reveals how far the field has to go.

CRISPR will allow you to-- do many different things. You can cut it-- to edit it. Bill Whitaker: So you can snip out the bad part and you can add something that you want as well?